
AFFINITY ASSET ADVISORS, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ESTA | 310K | $12.71M |
![]() | VERA | 303K | $8.81M |
![]() | CLDX | 300K | $7.76M |
![]() | IMVT | 300K | $4.84M |
![]() | QURE | 300K | $17.51M |
![]() | ATXS | 300K | $2.18M |
![]() | MRUS | 286K | $26.91M |
![]() | NAMS | 275K | $7.82M |
![]() | CGEM | 264K | $1.56M |
![]() | DNTH | 262K | $10.31M |
![]() | OACCU | 250K | $2.66M |
![]() | OLMA | 250K | $2.45M |
![]() | VRDN | 250K | $5.39M |
![]() | OCUL | 239K | $2.79M |
![]() | PTGX | 221K | $14.65M |
![]() | RPTX | 200K | $352.00K |
![]() | SLNO | 200K | $13.52M |
![]() | CMPS | 200K | $1.15M |
![]() | MBX | 165K | $2.89M |
![]() | TARS | 125K | $7.43M |

Establishment Labs Holdings Inc.
ESTA
Shares Held
310K
Value
$12.71M

Vera Therapeutics, Inc.
VERA
Shares Held
303K
Value
$8.81M

Celldex Therapeutics, Inc.
CLDX
Shares Held
300K
Value
$7.76M

Immunovant, Inc.
IMVT
Shares Held
300K
Value
$4.84M

uniQure N.V.
QURE
Shares Held
300K
Value
$17.51M

Astria Therapeutics, Inc.
ATXS
Shares Held
300K
Value
$2.18M

Merus N.V.
MRUS
Shares Held
286K
Value
$26.91M

NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
275K
Value
$7.82M

Cullinan Therapeutics, Inc.
CGEM
Shares Held
264K
Value
$1.56M

Dianthus Therapeutics, Inc.
DNTH
Shares Held
262K
Value
$10.31M

Oaktree Acquisition Corp. III Life Sciences Unit
OACCU
Shares Held
250K
Value
$2.66M

Olema Pharmaceuticals, Inc.
OLMA
Shares Held
250K
Value
$2.45M

Viridian Therapeutics, Inc.
VRDN
Shares Held
250K
Value
$5.39M

Ocular Therapeutix, Inc.
OCUL
Shares Held
239K
Value
$2.79M

Protagonist Therapeutics, Inc.
PTGX
Shares Held
221K
Value
$14.65M

Repare Therapeutics Inc.
RPTX
Shares Held
200K
Value
$352.00K

Soleno Therapeutics, Inc.
SLNO
Shares Held
200K
Value
$13.52M

COMPASS Pathways plc
CMPS
Shares Held
200K
Value
$1.15M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
165K
Value
$2.89M

Tarsus Pharmaceuticals, Inc.
TARS
Shares Held
125K
Value
$7.43M
